Purple Biotech (PPBT) Profit After Tax Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 119.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.52% |
| Dec 31, 2025 | 5,596.87% |
| Sep 30, 2025 | 95.36% |
| Jun 30, 2025 | -54.91% |
| Mar 31, 2025 | 87.94% |
| Dec 31, 2024 | -91.46% |
| Sep 30, 2024 | -86.79% |
| Jun 30, 2024 | -53.20% |
| Mar 31, 2024 | -177.12% |
| Dec 31, 2023 | -19.59% |
| Sep 30, 2023 | 4.25% |
| Jun 30, 2023 | 45.27% |
| Mar 31, 2023 | 167.02% |
| Dec 31, 2022 | 18.35% |
| Sep 30, 2022 | 53.99% |
| Jun 30, 2022 | -2.52% |
| Mar 31, 2022 | -213.73% |
| Dec 31, 2021 | 2,079.07% |
| Dec 31, 2020 | 92.15% |
| Dec 31, 2019 | -951.55% |
| Dec 31, 2018 | -94.41% |
| Dec 31, 2017 | -43.09% |
| Dec 31, 2016 | 188.55% |
| Dec 31, 2015 | 143.30% |
| Sep 30, 2015 | 0.96% |